| Literature DB >> 23126239 |
Davide V Moretti1, Donata Paternicò, Giuliano Binetti, Orazio Zanetti, Giovanni B Frisoni.
Abstract
GM (grey matter) changes of thalamus and basal ganglia have been demonstrated to be involved in AD (Alzheimer's disease). Moreover, the increase of a specific EEG (electroencephalogram) marker, α3/α2, have been associated with AD-converters subjects with MCI (mild cognitive impairment). To study the association of prognostic EEG markers with specific GM changes of thalamus and basal ganglia in subjects with MCI to detect biomarkers (morpho-physiological) early predictive of AD and non-AD dementia. Seventy-four adult subjects with MCI underwent EEG recording and high-resolution 3D MRI (three-dimensional magnetic resonance imaging). The α3/α2 ratio was computed for each subject. Three groups were obtained according to increasing tertile values of α3/α2 ratio. GM density differences between groups were investigated using a VBM (voxel-based morphometry) technique. Subjects with higher α3/α2 ratios when compared with subjects with lower and middle α3/α2 ratios showed minor atrophy in the ventral stream of basal ganglia (head of caudate nuclei and accumbens nuclei bilaterally) and of the pulvinar nuclei in the thalamus; The integrated analysis of EEG and morpho-structural markers could be useful in the comprehension of anatomo-physiological underpinning of the MCI entity.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23126239 PMCID: PMC3522208 DOI: 10.1042/AN20120058
Source DB: PubMed Journal: ASN Neuro ISSN: 1759-0914 Impact factor: 4.146
Figure 1GM density in high versus low α3/α2 power ratio
T-map showing greater regional GM density in patients with high α3/α2 ratio contrasted with patients with low α3/α2 ratio (P≤0.05 uncorrected, the symbol ‘>‘ denotes ‘major GM density then’; see also Table 1).
Demographic and cognitive characteristics in the whole sample disaggregated for increased levels of α3/α2 ratio
Numbers denote means±S.D., number and (range).
| α3/α2 | |||||
|---|---|---|---|---|---|
| All | High | Middle | Low | ||
| Number of subjects | 74 | 18 | 38 | 18 | |
| Age (years) | 69.4±0.6 (52–85) | 70.4±6.7 (60–85) | 68.4±8.2 (52–83) | 70.4±7.4 (57–80) | 0.55 |
| Sex (percentage female) | 51 | 13 | 24 | 14 | 0.51 |
| Education (years) | 7.6±3.9 (3–18) | 6.6±3.6 (4–18) | 7.6±3.7 (3–17) | 8.3±4.7 (3–18) | 0.42 |
| Mini mental state exam | 27.2±1.7 (23–30) | 26.9±1.3 (23–29) | 27±1.7 (24–30) | 27.4±1.2 (23–30) | 0.46 |
| α3/α2 | 1.09±0.15 (0.77–1.52) | 1.29±0.1 (1.17–1.52) | 1.08±0.0 (1–1.16) | 0.9±0.1 (0.77–0.98) | 0.000 |
P denotes significance on ANOVA (continuous variables) and chi-square test (dichotomous variables).
Figure 2GM density in high versus middle α3/α2 power ratio
T-map showing greater regional GM density in patients with high α3/α2 ratio contrasted with patients with middle α3/α2 ratio (P≤0.05 uncorrected, the symbol ‘>’ denotes ‘major GM density then’; see also Table 1).